Date Title Description PDF
06 Nov 2025 On P&L The Company releases the press release related to the first nine months of 2025 financial results Download
06 Nov 2025 On P&L The Company releases the first nine months of 2025 financial results presentation Download
21 Oct 2025 On business and financial situation The Company releases the press release in relation to the announcement of the collaboration with Roche for the manufacture of a new medicine in development Download
29 Sep 2025 On corporate transactions: mergers, acquisitions and others ROVI announces the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA) Download
29 Sep 2025 On corporate transactions: mergers, acquisitions and others The Company releases the presentation related to the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA) Download

Pages

Date Title Description PDF
16 Jun 2022 Other relevant information The Company has agreed to execute the capital reduction approved by the 2022 Ordinary General Meeting to amortize the shares acquired in the framework of the own shares repurchase programs   Download
14 Jun 2022 Announcement of general shareholders’ meeting ROVI releases the information related to its General Shareholders Meeting Download
11 May 2022 Announcement of general shareholders’ meeting Rovi releases the information related to its 2022 General Shareholders Meeting Download
11 May 2022 On Corporate Governance The Company informs about the appointment of a new member in its Board of Directors       Download
11 May 2022 On business and financial situation The Company releases the press release related to the first quarter 2022 financial result Download

Pages

Date Title Description PDF
21 Feb 2013 Información sobre resultados (2) Download
21 Feb 2013 Información sobre resultados Download
21 Feb 2013 Informe Anual de Gobierno Corporativo 2012 Download
08 Nov 2012 Información financiera intermedia Download
08 Nov 2012 Información sobre resultados Download

Pages